Revium Rx. (RVRC): EPS (Basic)

Annual figures by period end, from SEC filings.

-$0.22

Year ended 2025-12-31

Period ended	EPS (Basic)	Change YoY	Source filing
2025-12-31	-$0.22	n/a	2026-03-31, From 2025-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EPS (Basic)	Change YoY
Revium Rx. (RVRC)	2025-12-31	-$0.22	n/a
Lunai Bioworks Inc. (LNAI)	2025-06-30	-$1.08	n/m
Xenetic Biosciences, Inc. (XBIO)	2025-12-31	-$1.58	n/m
GT Biopharma, Inc. (GTBP)	2025-12-31	-$6.68	n/m
CNS Pharmaceuticals, Inc. (CNSP)	2025-12-31	-$35.75	n/m
GRI Bio, Inc. (GRI)	2025-12-31	-$121.80	n/m
IGC Pharma, Inc. (IGC)	2025-03-31	-$0.09	n/m
Dermata Therapeutics, Inc. (DRMA)	2025-12-31	-$8.16	n/m
Processa Pharmaceuticals, Inc. (PCSA)	2025-12-31	-$10.36	n/m

Compare RVRC, LNAI, XBIO, GTBP side by side · Screen every company in Pharmaceutical Preparations ↗